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Gene expressionThe Ts1Cje mouse model of Down syndrome (DS) has partial trisomy of mouse chromosome 16 (MMU16),
which is syntenic to human chromosome 21 (HSA21). It develops various neuropathological features demon-
strated by DS patients such as reduced cerebellar volume [1] and altered hippocampus-dependent learning
and memory [2,3]. To understand the global gene expression effect of the partially triplicated MMU16 segment
on mouse brain development, we performed the spatiotemporal transcriptome analysis of Ts1Cje and disomic
control cerebral cortex, cerebellum and hippocampus harvested at four developmental time-points: postnatal
day (P)1, P15, P30 and P84. Here, we provide a detailed description of the experimental and analysis procedures
of the microarray dataset, which has been deposited in the Gene Expression Omnibus (GSE49050) database.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Experimental design, materials and methods
Experimental approach
Three main brain regions including the cerebral cortex, cerebellum
and hippocampus were targeted in the study. Transcriptomes of these
brain regions from 3 Ts1Cje and 3 disomic littermate control were
compared at each of the following time-points: P1, P15, P30 and P84.
The tissue samples were randomised prior to RNA extraction, quantita-
tion of total RNA and quality/integrity, cRNA preparation andmicroarray
hybridisation steps (Table 1). Fig. 1(A) is a simpliﬁed diagram of the
experimental design anddata processingﬂow/criteria used for the study.
Ts1Cje mouse breeding, ethics statement and genotyping
Ts1Cje and disomic mice were generated by mating Ts1Cje males
(originally obtained from The Jackson Laboratory, Bar Harbour, USA)e CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Sample randomisation prior to RNA extraction, determination of total RNA sample quality/
integrity, cRNA preparation and microarray hybridization steps.
Day Week Tube Mouse ID Strain Age Tissue Accession ID
1 1 1 10.1.1 Disomic P1 Hippocampus GSM1193014
1 1 2 A40 Ts1Cje P84 Cerebral cortex GSM1193015
1 1 3 A104 Ts1Cje P30 Cerebral cortex GSM1193016
1 1 4 10.1.3 Ts1Cje P1 Cerebellum GSM1193017
1 1 5 A104 Ts1Cje P30 Hippocampus GSM1193018
1 1 6 A63 Disomic P15 Cerebral cortex GSM1193019
2 1 7 A40 Ts1Cje P84 Cerebellum GSM1193020
2 1 8 10.1.1 Disomic P1 Cerebellum GSM1193021
2 1 9 A41 Disomic P84 Hippocampus GSM1193022
2 1 10 A60 Ts1Cje P15 Cerebral cortex GSM1193023
2 1 11 A40 Ts1Cje P84 Hippocampus GSM1193024
2 1 12 10.1.3 Ts1Cje P1 Hippocampus GSM1193025
3 1 13 A103 Disomic P30 Hippocampus GSM1193026
3 1 14 A41 Disomic P84 Cerebellum GSM1193027
3 1 15 A63 Disomic P15 Hippocampus GSM1193028
3 1 16 A41 Disomic P84 Cerebral cortex GSM1193029
3 1 17 A60 Ts1Cje P15 Hippocampus GSM1193030
3 1 18 A104 Ts1Cje P30 Cerebellum GSM1193031
4 1 19 A103 Disomic P30 Cerebellum GSM1193032
4 1 20 10.1.3 Ts1Cje P1 Cerebral cortex GSM1193033
4 1 21 A60 Ts1Cje P15 Cerebellum GSM1193034
4 1 22 A103 Disomic P30 Cerebral cortex GSM1193035
4 1 23 A63 Disomic P15 Cerebellum GSM1193036
4 1 24 10.1.1 Disomic P1 Cerebral cortex GSM1193037
5 2 25 A44 Ts1Cje P84 Hippocampus GSM1193038
5 2 26 10.1.5 Ts1Cje P1 Cerebellum GSM1193039
5 2 27 A91 Disomic P15 Hippocampus GSM1193041
5 2 28 105 Disomic P30 Cerebral cortex GSM1193044
5 2 29 105 Disomic P30 Hippocampus GSM1193048
5 2 30 10.1.5 Ts1Cje P1 Hippocampus GSM1193049
6 2 31 A91 Disomic P15 Cerebellum GSM1193050
6 2 32 A33 3.2.4 Ts1Cje P30 Cerebellum GSM1193051
6 2 33 10.1.2 Disomic P1 Cerebral cortex GSM1193052
6 2 34 10.1.5 Ts1Cje P1 Cerebral cortex GSM1193053
6 2 35 10.1.2 Disomic P1 Cerebellum GSM1193054
6 2 36 A92 Ts1Cje P15 Cerebral cortex GSM1193055
7 2 37 10.1.2 Disomic P1 Hippocampus GSM1193056
7 2 38 A33 3.2.4 Ts1Cje P30 Hippocampus GSM1193057
7 2 39 A42/43 Disomic P84 Cerebellum GSM1193058
7 2 40 A91 Disomic P15 Cerebral cortex GSM1193059
7 2 41 A42/43 Disomic P84 Cerebral cortex GSM1193060
7 2 42 A92 Ts1Cje P15 Cerebellum GSM1193061
8 2 43 105 Disomic P30 Cerebellum GSM1193062
8 2 44 A42/43 Disomic P84 Hippocampus GSM1193063
8 2 45 A92 Ts1Cje P15 Hippocampus GSM1193064
8 2 46 A44 Ts1Cje P84 Cerebral cortex GSM1193065
8 2 47 A33 3.2.4 Ts1Cje P30 Cerebral cortex GSM1193066
8 2 48 A44 Ts1Cje P84 Cerebellum GSM1193067
9 3 49 A76 Ts1Cje P15 Cerebellum GSM1193068
9 3 50 A34 3.2.5 Ts1Cje P30 Hippocampus GSM1193069
9 3 51 10.1.9 Ts1Cje P1 Cerebellum GSM1193070
9 3 52 106 Disomic P30 Cerebellum GSM1193071
9 3 53 A49 Ts1Cje P84 Hippocampus GSM1193072
9 3 54 A76 Ts1Cje P15 Hippocampus GSM1193073
10 3 55 A76 Ts1Cje P15 Cerebral cortex GSM1193074
10 3 56 10.1.7 Disomic P1 Hippocampus GSM1193075
10 3 57 106 Disomic P30 Cerebral cortex GSM1193076
10 3 58 A49 Ts1Cje P84 Cerebellum GSM1193077
10 3 59 A50 Disomic P84 Hippocampus GSM1193078
10 3 60 A49 Ts1Cje P84 Cerebral cortex GSM1193079
11 3 61 A50 Disomic P84 Cerebellum GSM1193080
11 3 62 10.1.9 Ts1Cje P1 Cerebral cortex GSM1193081
11 3 63 A34 3.2.5 Ts1Cje P30 Cerebral cortex GSM1193082
11 3 64 10.1.7 Disomic P1 Cerebral cortex GSM1193083
11 3 65 A34 3.2.5 Ts1Cje P30 Cerebellum GSM1193084
11 3 66 A75 Disomic P15 Cerebral cortex GSM1193085
12 3 67 A75 Disomic P15 Hippocampus GSM1193086
12 3 68 10.1.7 Disomic P1 Cerebellum GSM1193087
12 3 69 A75 Disomic P15 Cerebellum GSM1193088
12 3 70 10.1.9 Ts1Cje P1 Hippocampus GSM1193089
12 3 71 106 Disomic P30 Hippocampus GSM1193090
12 3 72 A50 Disomic P84 Cerebral cortex GSM1193091
315K.-L. Tan et al. / Genomics Data 2 (2014) 314–317with C57BL/6 femalemice for over 10 generations. All micewere kept in
a controlled environment of 12-h light/12-h dark cycle with unlimited
access to a standard pellet diet and water. Breeding procedures,
husbandry and all experiments were performed under the approval
from the Walter and Eliza Hall Institute Animal Ethics Committee
(Project numbers 2001.45, 2004.041 and 2007.007). Genomic DNA
was extracted from mouse-tails and genotyping was performed using
multiplex PCR with primers for neomycin (neo) and the glutamate re-
ceptor, ionotropic, kainite 1 (Grik1) as an internal control as described
previously [4].
Tissue procurement
Three female Ts1Cjemice at four time-points (P1, P15, P30 and P84)
with sex and age matched disomic littermates were used to avoid the
effects of Y-linked genes such as Sry (sex-determining region of the Y
chromosome), which contribute to neural sexual differentiation of the
brain [5]. All mice were euthanized via cervical dislocation. Procurement
of the cerebral cortex, cerebellum and hippocampus was conducted
according to a method described previously [6].
RNA extraction and microarray hybridisation
The Qiagen RNeasy Micro kit (Qiagen) with a DNase I digestion step
was used to extract total RNA from each tissue according to the
manufacturer's instructions. All 72 tissues were randomised prior to
RNA extraction to avoid biases (Table 1). The quality and quantity of
each RNA sample were assessed using an Agilent 2100 Bioanalyzer
(Agilent). The RNA Integrity Number (RIN) ranged from 7.0 to 10. Six
micrograms of total RNAwas used to prepare biotinylated cRNA accord-
ing to the standard Affymetrix protocol (Expression Analysis Technical
Manual, 2001, Affymetrix). Hybridisation of labelled RNA samples
onto Affymetrix GeneChip Mouse Genome 430 2.0 Arrays was per-
formed according to the Australian Genome Research Facility (AGRF)
protocol. A probe cocktail (cRNA at 0.05 μg/μl), which included 1×
Hybridisation Buffer (100 mM MES, 1 M NaCl, 20 mM EDTA, 0.01%
Tween-20), 0.1 mg/ml Herring Sperm DNA, 0.5 mg/ml BSA, and 7%
DMSO was prepared to a total of 300 μl for each sample and 200 μl
was hybridised onto a single GeneChip. The chips were incubated at
45 °C for 16 h in an oven with a rotating wheel at 60 rpm, washed
and stained with streptavidin-phycoerythrin (SAPE) using the appro-
priateﬂuidics script on the Affymetrix Fluidics Station 450 (Affymetrix).
The GeneChips were scanned using a GeneChip Scanner 3000®
(Affymetrix) with GeneChip® Operating Software (GCOS).
Fig. 1(B) shows a simpliﬁed diagram of the sample preparation.
Microarray data normalisation and analysis
The microarray data was analysed using R (www.r-project.org) and
Bioconductor (www.bioconductor.org) [7]. The probe-level intensities for
the 72 arrays were background corrected, normalised and summarised
using the GC Robust Multi-array Average (GC-RMA) algorithm [8] to
obtain gene (probe-set) level summaries (see Supplementary File 1 for
GC-RMA script used). Differential expression between Ts1Cje and their
disomic littermates at different time-points and in different brain regions
was assessed using the limma package [9]. A linear model was ﬁtted for
multiple contrasts (corresponding to the Ts1Cje vs disomic comparisons)
for each gene using the lmFit procedure and differential expression wasNotes to Table 1:
Note: ‘Day’ and ‘Week’ refer to the different days in differentweeks onwhich RNAwas ex-
tracted from these samples. All samples were relabelled with a set of continuous numbers
under the ‘Tube’ column. ‘Mouse ID’ refers to the internal identiﬁcation number used in
the animal facilities where these mice were bred and maintained. ‘Accession ID’ refers to
GEO sample ID deposited under the GSE49050 data series. Within the ‘Strain’ column,
Ts1Cje denotesmousemodel of Down syndromemice. Under the ‘Age’ column, P denotes
‘Postnatal Development Day’.
316 K.-L. Tan et al. / Genomics Data 2 (2014) 314–317assessed using empirical Bayes moderated t-statistics [10]. P-values cor-
responding to the moderated t-statistics were adjusted for multiple test-
ing using the false discovery rate (FDR) procedure of Benjamini and
Hochberg [11]. Fig. 1(C) shows a simpliﬁed diagram of the microarray
analysis.
Stringent criteria were applied to identify differentially expressed
genes (DEGs) from the datasets, which included t-statistic values of
≥4 or ≤ -4 and a FDR of ≤0.05. As reported in Ling et al. [12], a total
number of 317 DEGs were identiﬁed from all spatiotemporal compari-
sons. A top-down screening approach was then used to analyse the
317 DEGs in order to identify any disrupted molecular pathways.
Initially, a functional ontology clustering analysis based on all 317
DEGs collectively using the Database for Annotation, Visualisation andFig. 1.Outline of experimental design (A), sample preparation (B), microarray data analysis (C)
mice, cRNA denotes complementary RNA, GCRMA denotes Guanine Cytosine Robust Multi-A
Visualization and Integrated Discovery.Integrated Discovery (DAVID) [13] was performed. The functional clus-
tering analysis was performed under a stringent classiﬁcation criteria
(a kappa similarity threshold of 0.85, a minimum term overlap of three,
two initial and ﬁnal group membership with a 0.50 multiple linkage
threshold and amodiﬁed Fisher-exact P-value or enrichment thresholds
of 0.05) using the following databases: Biological Biochemical Image
Database (BBID), BioCarta database, EC_number, Kyoto Encyclopedia of
Genes and Genomes (KEGG) database, PANTHER pathway database
and Reactome pathway database [13]. Subsequently, a more reﬁned
analysis was carried out involving the DEGs identiﬁed from the compar-
isons that were based on a speciﬁc time-point or brain region. Finally,
the signiﬁcant ontologies identiﬁed through all analyses were manually
curated based on common genes that were found involved in the, and functional clustering analysis using DAVID tools (D). Ts1Cje denotes Down syndrome
rray Analysis, FDR denotes false discovery rate, DAVID denotes Database for Annotation,
317K.-L. Tan et al. / Genomics Data 2 (2014) 314–317ontologies leading to the identiﬁcation of 7 signiﬁcant functional clus-
ters. Fig. 1(D) shows a simpliﬁed diagram of the functional clustering
analysis.Discussion
Here we provide a detailed description of the generation of a 72
microarray dataset, which is comprised of transcriptome proﬁling data
derived from three brain regions, at four postnatal time-points from
the Ts1Cje mouse model of DS and disomic littermates. The strategy
used to identify DEGs between the Ts1Cje and disomic littermate data
and functional clustering analysis is also described. This comprehensive
and well-controlled microarray dataset encompasses postnatal devel-
opmental stages from P1 to P84 in the cerebral cortex, cerebellum
and hippocampus providing a platform to understand the differences
between the Ts1Cje and disomicmouse brain in these regions at a tran-
scriptome level. The analysis of the dataset was fully described and
discussed in the study by Ling et al. [12], which demonstrated that the
interferon-related pathways were signiﬁcantly dysregulated in the
Ts1Cje brain as compared to their disomic littermates.Acknowledgement
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